Coherus Oncology, Inc. (CHRS)
0.8327
-0.07
(-7.31%)
USD |
NASDAQ |
Oct 30, 16:00
0.8327
0.00 (0.00%)
After-Hours: 16:52
Coherus Oncology Cash and Short Term Investments (Annual) : 172.12M for Dec. 31, 2025
Cash and Short Term Investments (Annual) Chart
Historical Cash and Short Term Investments (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 172.12M |
| December 31, 2024 | 125.99M |
| December 31, 2023 | 117.75M |
| December 31, 2022 | 191.68M |
| December 31, 2021 | 417.20M |
| December 31, 2020 | 541.16M |
| December 31, 2019 | 177.67M |
| Date | Value |
|---|---|
| December 31, 2018 | 72.41M |
| December 31, 2017 | 126.97M |
| December 31, 2016 | 125.01M |
| December 31, 2015 | 158.29M |
| December 31, 2014 | 150.45M |
| December 31, 2013 | 39.60M |
| December 31, 2012 | 14.60M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Annual) Benchmarks
| Enanta Pharmaceuticals, Inc. | 188.86M |
| ACADIA Pharmaceuticals, Inc. | 819.69M |
| Alnylam Pharmaceuticals, Inc. | 2.908B |
| Anika Therapeutics, Inc. | 57.48M |
| Savara, Inc. | 235.70M |